TotalMarketCap

Atrium Therapeutics

RNANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$143.516 M

$8.39 -3.34%

Close of 6 Nov 2026

As of 6 Nov 2026, Atrium Therapeutics (RNA) has a market capitalization of $143.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

17,105,643

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #263AN2 TherapeuticsANTX$149.8M
  2. #264Sionna TherapeuticsSION$147.8M
  3. #265Atrium TherapeuticsRNA$143.5M
  4. #266MacrogenicsMGNX$143.3M
  5. #267Alx OncologyALXO$143.0M

What if Atrium Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,650,734

Per share 196,750× higher

Bitcoin $1.53T

$89,318.37

Per share 10,646× higher

Apple $5.02T

$293,223.86

Per share 34,949× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Atrium Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.